-
CTMX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
CytomX Therapeutics (CTMX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 41.60 mm | 41.60 mm | 41.60 mm | 41.60 mm | 41.60 mm | 41.60 mm |
Cash burn (monthly) | 853.67 k | (no burn) | (no burn) | (no burn) | 6.91 mm | 7.36 mm |
Cash used (since last report) | 3.43 mm | n/a | n/a | n/a | 27.79 mm | 29.59 mm |
Cash remaining | 38.17 mm | n/a | n/a | n/a | 13.81 mm | 12.01 mm |
Runway (months of cash) | 44.7 | n/a | n/a | n/a | 2.0 | 1.6 |
13F holders | Current |
---|---|
Total holders | 71 |
Opened positions | 10 |
Closed positions | 16 |
Increased positions | 19 |
Reduced positions | 23 |
13F shares | Current |
---|---|
Total value | 56.57 bn |
Total shares | 68.26 mm |
Total puts | 8.30 k |
Total calls | 112.00 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Biotechnology Value Fund L P | 8.09 mm | $8.03 mm |
Tang Capital Management | 7.81 mm | $9.22 bn |
Tang Capital Partners | 6.55 mm | $10.28 mm |
BVF | 5.23 mm | $6.17 bn |
Vanguard | 5.16 mm | $6.09 bn |
JHG Janus Henderson | 4.81 mm | $5.70 bn |
Acadian Asset Management | 3.10 mm | $3.66 mm |
Prosight Management | 3.02 mm | $3.57 bn |
Adage Capital Partners GP, L.L.C. | 3.00 mm | $3.54 bn |
Millennium Management | 2.56 mm | $3.02 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Aug 24 | Christopher Ogden | Common Stock | Sell | Dispose S | No | No | 1.2291 | 1,984 | 2.44 k | 108,077 |
20 Aug 24 | Christopher Ogden | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,875 | 0.00 | 110,061 |
20 Aug 24 | Christopher Ogden | Performance Stock Units (PSUs) Common Stock | Option exercise | Dispose M | No | No | 0 | 6,875 | 0.00 | 0 |
20 Aug 24 | Marcia Belvin | Common Stock | Sell | Dispose S | No | No | 1.2291 | 4,181 | 5.14 k | 175,648 |
20 Aug 24 | Marcia Belvin | Common Stock | Option exercise | Acquire M | No | No | 0 | 11,250 | 0.00 | 179,829 |
20 Aug 24 | Marcia Belvin | Performance Stock Units (PSUs) Common Stock | Option exercise | Dispose M | No | No | 0 | 11,250 | 0.00 | 0 |
20 Aug 24 | McCarthy Sean A. | Common Stock | Sell | Dispose S | No | No | 1.2291 | 13,898 | 17.08 k | 657,851 |
20 Aug 24 | McCarthy Sean A. | Common Stock | Option exercise | Acquire M | No | No | 0 | 37,500 | 0.00 | 671,749 |
20 Aug 24 | McCarthy Sean A. | Performance Stock Units (PSUs) Common Stock | Option exercise | Dispose M | No | No | 0 | 37,500 | 0.00 | 0 |
20 Aug 24 | Lloyd A Rowland | Common Stock | Sell | Dispose S | No | No | 1.2291 | 4,181 | 5.14 k | 130,797 |